Maptelligent, Inc. MAPT
0.00 USD 0.00 (+0.00%)
At closeNov 2, 2026, 4:00 PM EST
0.0005 Day range 0.0005
0.0001 52-week range 0.001
- YTD
- +233.33%
- 1 year
- +233.33%
- Market cap
- 2.50M
- EPS (ttm)
- 0.02
- P/E ratio
- 0.05
- YTD return
- +233.33%
- 1-year return
- +233.33%
- Volume
- 10.00K
- Avg volume
- 5
- Open
- 0.0005
- Previous close
- 0.001
- Day's range
- 0.0005 – 0.0005
- 52-week range
- 0.0001 – 0.001
2Y +0.0006 (+150.00%)
News
Arrowhead Pharmaceuticals: ARO-MAPT Results Unlock A New Platform 
Arrowhead Pharmaceuticals Announces ARO-MAPT Interim Phase 1/2a Clinical Data Demonstrating Deep and Durable Tau Reductions in Healthy Volunteers 
Arrowhead Pharmaceuticals to Host a Webinar with Interim Clinical Data from a Phase 1/2a Study of ARO-MAPT for the Treatment of Alzheimer's Disease and Other Tauopathies 
Ionis Partner Biogen Presents Phase 2 CELIA Data at AAIC Demonstrating Meaningful Clinical Outcomes and Robust Tau Reduction with Diranersen in Early Alzheimer's Disease 
Arrowhead Pharmaceuticals Initiates Phase 1/2a Study of ARO-MAPT for the Treatment of Alzheimer's Disease and Other Tauopathies 
Arrowhead Pharmaceuticals Requests Regulatory Clearance to Initiate Phase 1/2a Study of ARO-MAPT for the Treatment of Alzheimer's Disease and Other Tauopathies 
Maptelligent, Inc., is Pleased to Announce it has Entered Into an Agreement With Axim Geospatial 
Maptelligent is Pleased to Announce Its New Strategic Focus, Implementing the Latest in Location Intelligence Making Indoor Maps More Intelligent 
Maptelligent, Inc., is Pleased to Announce a Partnership with Michael Quan with the Interactive Tactical Group 
NSION Technologies & Maptelligent Strategic Partnership
Your note
Sign in to keep a note on MAPT — it syncs with the Stock Master app.